The effectiveness of hardware CPAP therapy in heart failure with preserved left ventricular ejection fraction and obstructive sleep apnea syndrome
- Authors: Yakovlev A.V.1, Efremov I.A.1, Yakovlevа N.F.1, Shilov S.N.1, Ryabikov A.N.1, Teplyakov A.T.2, Grakova E.V.2, Kopeva K.V.2, Shirokikh I.V.3
-
Affiliations:
- Novosibirsk State Medical University
- Tomsk National Research Medical Center
- Federal Center for Traumatology, Orthopedics and Arthroplasty
- Issue: Vol 96, No 1 (2024)
- Pages: 36-41
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/258640
- DOI: https://doi.org/10.26442/00403660.2024.01.202563
- ID: 258640
Cite item
Full Text
Abstract
Aim. To evaluate the effectiveness of hardware Continuous Positive Airway Pressure therapy (CPAP therapy) and its likely predictors in patients with heart failure with preserved ejection fraction (HFpEF) associated with obstructive sleep apnea syndrome (OSAS).
Materials and methods. The study involved 207 men with HFpEF and OSAS (apnea/hypopnea index >15 per hour) who did not initially have ischemic disease and other structural heart pathology. At inclusion in the study, polysomnography and echocardiography were performed with an assessment of diastolic function and global longitudinal deformation of the left ventricular myocardium, as well as a 6-minute walk test (6MWT) and the level of the brain natriuretic peptide precursor (NT-proBNP) in the blood was determined. 80 patients received hardware CPAP the rapy, 127 patients made up the control group. After 12 months, 6MWT was repeated, NT-proBNP was determined, and clinical outcomes were assessed retrospectively.
Results. The CPAP group had 16% fewer hospitalizations (p=0.011 [95% confidence interval – CI 4.29]) and showed a trend towards an increase in the 6MWT distance (p=0.065). To assess the likely predictors of the effectiveness of CPAP therapy, a subgroup of “responders” was identified, characterized by an increase in the distance according to the 6MWT, a decrease in the level of NT-proBNP, and the absence of adverse clinical events during the observation period. There were significant differences between responders and non-responders in apnea/hypopnea index (p=0.01 [95% CI -10.6; -2.5]), global longitudinal deformation of the left ventricular myocardium (p=0.05 [95% CI -4.7; 0]), diastolic function E/A (p=0.02 [95% CI -0.1; 0]).
Conclusion. CPAP therapy improves clinical outcomes and functional status in patients with OSAS-associated HFpEF. The predictive model built using the identified efficacy predictors can be used to develop a personalized treatment algorithm for this cohort of patients.
Full Text
##article.viewOnOriginalSite##About the authors
Alexey V. Yakovlev
Novosibirsk State Medical University
Author for correspondence.
Email: alex-yak-card@mail.ru
ORCID iD: 0000-0002-4763-0961
Cand. Sci. (Med.), Novosibirsk State Medical University
Russian Federation, NovosibirskIvan A. Efremov
Novosibirsk State Medical University
Email: mr.and1997@inbox.ru
ORCID iD: 0000-0002-1704-2528
Postgraduate student, Department of Therapy, Hematology and Transfusiology
Russian Federation, NovosibirskNatalia F. Yakovlevа
Novosibirsk State Medical University
Email: yakovlevanf@yandex.ru
ORCID iD: 0000-0002-4736-6486
Cand. Sci. (Med.), Novosibirsk State Medical University
Russian Federation, NovosibirskSergey N. Shilov
Novosibirsk State Medical University
Email: newsib54@gmail.com
ORCID iD: 0000-0002-7777-6419
D. Sci. (Med.), Novosibirsk State Medical University
Russian Federation, NovosibirskAndrey N. Ryabikov
Novosibirsk State Medical University
Email: andrew_ryabikov@mail.ru
ORCID iD: 0000-0001-9868-855X
MD, PhD, DSc, Professor, Department of Therapy, Hematology and Transfusiology
Russian Federation, NovosibirskAlexander T. Teplyakov
Tomsk National Research Medical Center
Email: vgelen1970@gmail.ru
ORCID iD: 0000-0003-0721-0038
D. Sci. (Med.), Prof.
Russian Federation, TomskElena V. Grakova
Tomsk National Research Medical Center
Email: gev@cardio-tomsk.ru
ORCID iD: 0000-0003-4019-3735
D. Sci. (Med.)
Russian Federation, TomskKristina V. Kopeva
Tomsk National Research Medical Center
Email: kristin-kop@inbox.ru
ORCID iD: 0000-0002-2285-6438
Cand. Sci. (Med.)
Russian Federation, TomskIlya V. Shirokikh
Federal Center for Traumatology, Orthopedics and Arthroplasty
Email: shir413@mail.ru
ORCID iD: 0000-0002-5324-3132
Resident Physician
Russian Federation, BarnaulReferences
- Бойцов С.А., Шальнова С.А., Деев А.Д. Эпидемиологическая ситуация как фактор, определяющий стратегию действий по снижению смертности в Российской Федерации. Терапевтический архив. 2020;92(1):4-9 [Boytsov SA, Shalnova SA, Deev AD. The epidemiological situation as a factor determining the strategy for reducing mortality in the Russian Federation. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(1):4-9 (in Russian)]. doi: 10.26442/00403660.2020.01.000510
- Медведева Е.А., Коростовцева Л.С., Сазонова Ю.В., и др. Синдром обструктивного апноэ во сне при хронической сердечной недостаточности: взгляд кардиолога. Российский кардиологический журнал. 2018;1:78-82 [Medvedeva EA, Korostovtseva LS, Sazonova YuV, et al. Obstructive sleep apnea syndrome in chronic heart failure: a cardiologist's perspective. Russian Journal of Cardiology. 2018;1:78-82 (in Russian)]. doi: 10.15829/1560-4071-2018-1-78-82
- Maeder MT, Schoch OD, Buser M, et al. Obstructive sleep apnea and heart failure. Cardiovascular Medicine. 2017;20(2):9-17. doi: 10.4414/cvm.2017.00452
- Бузунов Р.В., Пальман А.Д., Мельников А.Ю., и др. Диагностика и лечение синдрома обструктивного апноэ сна у взрослых. Рекомендации Российского общества сомнологов. Эффективная фармакотерапия. 2018;35:34-45 [Buzunov RV, Palman AD, Melnikov AYu, et al. Diagnostics and treatment of obstructive sleep apnea syndrome in adults. Recommendations of the Russian Society of Sleep Medicine. Effective Pharmacotherapy. 2018;35:34-45 (in Russian)].
- Picard F, Panagiotidou P, Weinig L, et al. Effect of CPAP therapy on nocturnal blood pressure fluctuations, nocturnal blood pressure, and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea. Sleep Breath. 2021;25(1):151-61. doi: 10.1007/s11325-020-02075-4
- Labarca G, Reyes T, Jorquera J, et al. CPAP in patients with obstructive sleep apnea and type 2 diabetes mellitus: Systematic review and meta-analysis. Clin Respir J. 2018;12(8):2361-8. doi: 10.1111/crj.12915
- Barros D, García-Río F. Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence. Sleep. 2019;42(3):zsy236. doi: 10.1093/sleep/zsy236
- Furlow B. SAVE trial: no cardiovascular benefits for CPAP in OSA. Lancet Respir Med. 2016;4(11):860. doi: 10.1016/S2213-2600(16)30300-9
- Carmo J, Araújo I, Marques F, Fonseca C. Sleep-disordered breathing in heart failure: The state of the art after the SERVE-HF trial. Rev Port Cardiol. 2017;36(11):859-67. doi: 10.1016/j.repc.2017.06.007
- Bakker JP, Weaver TE, Parthasarathy S, Aloia MS. Adherence to CPAP: What Should We Be Aiming For, and How Can We Get There? Chest. 2019;155(6):1272-87. doi: 10.1016/j.chest.2019.01.012
- Российское кардиологическое общество (РКО). Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083 [Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Сhronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083 (in Russian)]. doi: 10.15829/1560-4071-2020-4083
- Sun H, Shi J, Li M, Chen X. Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(5):e62298. doi: 10.1371/journal.pone.0062298
- Cifçi N, Uyar M, Elbek O, et al. Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath. 2010;14(3):241-4. doi: 10.1007/s11325-009-0306-y
- Hammerstingl C, Schueler R, Wiesen M, et al. Impact of untreated obstructive sleep apnea on left and right ventricular myocardial function and effects of CPAP therapy. PLoS One. 2013;8(10):e76352. doi: 10.1371/journal.pone.0076352
- Mazzotti DR, Keenan BT, Lim DC, et al. Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes. Am J Respir Crit Care Med. 2019;200(4):493-506. doi: 10.1164/rccm.201808-1509OC
- Peker Y, Glantz H, Eulenburg C, et al. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial. Am J Respir Crit Care Med. 2016;194(5):613-20. doi: 10.1164/rccm.201601-0088OC
- Tadic M, Gherbesi E, Faggiano A, et al. The impact of continuous positive airway pressure on cardiac mechanics: Findings from a meta-analysis of echocardiographic studies. J Clin Hypertens (Greenwich). 2022;24(7):795-803. doi: 10.1111/jch.14488
- Msaad S, Marrakchi R, Grati M, et al. How does serum brain natriuretic peptide level change under nasal continuous positive airway pressure in obstructive sleep apnea-hypopnea syndrome? Libyan J Med. 2016;11:31673. doi: 10.3402/ljm.v11.31673